GKOS stock gains as pivotal trials for eye implant reach main goals (NYSE:GKOS)

Published on 7 Sep 2022 on Seeking Alpha

Glaukos Corporation (GKOS), a MedTech company focused on eye diseases, announced Wednesday that two...

Read the rest of the article

Start tracking your investments with Statfolio

Glaukos Corporation GKOS is well-poised for growth, backed by favorable clinical trial results an...

Zacks via Yahoo Finance 15 Nov 2023

While Glaukos Corporation (NYSE:GKOS) might not be the most widely known stock at the moment, it ...

Simply Wall St. via Yahoo Finance 3 Nov 2023

Glaukos Corporation GKOS is well-poised for growth, backed by favorable clinical trial results an...

Zacks via Yahoo Finance 5 Oct 2023

Glaukos Corporation GKOS is well poised for growth, backed by favorable clinical trial results an...

Zacks via Yahoo Finance 14 Jul 2023

Glaukos Corporation GKOS is well poised for growth, backed by favorable clinical trial results an...

Zacks via Yahoo Finance 19 May 2023

Glaukos Corporation GKOS reported first-quarter 2023 adjusted loss of 59 cents per share, which w...

Zacks via Yahoo Finance 4 May 2023

You may think that with a price-to-sales (or "P/S") ratio of 8.2x Glaukos Corporation (NYSE:GKOS)...

Simply Wall St. via Yahoo Finance 17 Apr 2023

Celanese Corporation CE has signed a deal with Glaukos Corporation to supply its VitalDose Drug D...

Zacks via Yahoo Finance 6 Apr 2023

Alger Capital, an investment management company, released its “Alger Weatherbie Specialized Growt...

Insider Monkey via Yahoo Finance 27 Feb 2023

Glaukos Corporation GKOS reported an adjusted loss per share of 53 cents for the fourth quarter o...

Zacks via Yahoo Finance 23 Feb 2023